Autoimmune disease is a condition, where immune systems of human body considers the healthy cells as foreign cells and attacks them. The autoimmune disease can lead to abnormal organ growth and changed organ functions. The factors such as environmental exposure, and genetic factors are responsible to development of autoimmune disease. There are over 80 types of autoimmune disease, some of them are inflammatory bowel disease, type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. The cure for autoimmune disease is not yet discovered. However, there are some relieving treatments for these diseases in the market. The diagnosis of autoimmune disease requires tests that include antibody test, antinuclear antibody test, complete blood counts, and some other tests.
Get a PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/419
Increasing government initiatives and rising cases of autoimmune diseases are expected to fuel growth of the global autoimmune disease diagnostics market during the forecast period. For instance, in 2016, the American Autoimmune Related Disease Association (AARDA) reported that autoimmune disease affected nearly 50 million individuals in the U.S., where 75% were women.
Morover, growing geriatric population, technological development in the rheumatoid arthritis diagnosis, as well as government initiative for patients suffering from systemic lupus erythematosus and rheumatoid arthritis are also the factors expected to propel growth of the global autoimmune disease diagnostics market during the forecast period.
Factors such as high rate of wrong results, longer turnaround period for test results, and inadequate trained and experienced laboratory professionals in the certain autoimmune disease diagnostics are expected to hinder the growth of the global autoimmune disease diagnostics market during the forecast period.
The global autoimmune disease diagnostics market is regionally divided into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa.
Among regions, North America is expected to witness significant growth in the global autoimmune disease diagnostics market during the forecast period due to increasing cases of autoimmune diseases such as type 1 diabetes and rheumatoid arthritis, growing funding by private and government sectors, technological development and rising WHO-monitored regulatory scenario. Moreover, Asia Pacific is also expected to witness strong growth in the global autoimmune disease diagnostic market.
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/419
Major players active in global the autoimmune disease diagnostics market are Beckman Coulter, Euroimmun, Roche Diagnostics, A. Menarini Diagnostics, AESKU Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Inova Diagnostics, Siemens Healthcare, Adaptive Biotechnologies, and others.
In July 2019, Progentec Diagnostics, Inc. announced the merger with Karate Health, Inc, for offering digital technologies and laboratory testing for the management and diagnosis of autoimmune diseases.
In March, 2019 Eli Lilly collaborated with ImmuNext to study and develop a preclinical novel potential target for autoimmune disease treatments.
In January 2019, Vital Therapies, Inc., entered into a definitive agreement with Immunic AG to focus on Immunic‘s pipeline of new and potentially transformative treatments for autoimmune and chronic inflammatory diseases.
In 2018, Quidel Corporation, was granted CE mark for its Sofia Quantitative Vitamin D FIA to use it with Sofia fluorescent immunoassay analyzer.
In 2017, ImmunArray partnered with Kindstar Global Co., Ltd., and launched ImmunArray’s lupus rule-out test in China.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/419
The global autoimmune disease diagnostic market divided by disease type, test type, end user and geography
By Disease Type:
- Systemic Autoimmune Disease diagnostics
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Some Others
- Systemic Lupus Erythematosus
- Multiple Sclerosis
- Localized autoimmune disease diagnostics
- Hashimoto’s thyroiditis
- Type 1 diabetes
- Idiopathic Thrombocytopenic purpura
By Test Type:
- Antinuclear Antibody Tests
- Complete Blood Count
- Autoantibody Tests
- C-reactive Protein
By End User:
- Research Laboratories
- Diagnostics Centers
- North America
- Latin America
- Middle East
- Asia Pacific
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027